Skip to main content
KBS_Icon_questionmark link-ico


Dr. Thanou is a Reader in the Institute of Pharmaceutical Science at King’s. She finished her PhD in LACDR (Leiden/Amsterdam Centre for Drug Research)  in the area of therapeutic peptides for cancer. In 2000 she received the AAPS award for excellence in Graduate Research.

After a short period in Kytogenics Pharmaceuticals, she took her first academic appointment in the School of Pharmacy, Cardiff University as Lecturer in Polymer Therapeutics and Drug Delivery. In 2004 she was awarded the prestigious Dorothy Hodgkin Royal Society Research Fellowship and she continued research at Imperial College London, within the Department of Chemistry in the area of cancer gene therapy.

She moved to King’s in 2009. In her current role she is focusing in postgraduate teaching (Director of MSc Pharmaceutical Technology programme) and research in Chemical Biology. She is currently focusing on the chemical design and development of theranostic nanoparticles, de novo design of materials for microwave sensing and hyperthermia, as well as novel nanomaterials for fluorescence bioimaging (funded by EPSRC, BBSRC and King's Commercialisation Institute, Schlumberger Foundation).

Her research can be summarised on engineering image guided drug activation methods, using nanoparticles and medical devices. She collaborates with a number of companies (biotech, devices) and she has been awarded several BBSRC industrial case studentships. She is the main or co-inventor of eight patents and editor of a RSC book on Theranostics: Image Guided Drug Delivery. She is the science communicator for MyWave COST action and Trustee for industry engagement of the British Society of Nanomedicine.